Dosing

Wegovy Dosage Guide: From 0.25mg to 2.4mg Step by Step

GLP-1 Companion · 8 min read

Wegovy (semaglutide 2.4 mg) is FDA-approved for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related condition. It is the same active ingredient as Ozempic — semaglutide — but at a higher maximum dose (2.4 mg vs 2 mg) and with a different titration schedule designed specifically for weight management. Understanding the escalation schedule is key to managing side effects and reaching the maintenance dose.

The Complete Wegovy Titration Schedule

Wegovy is initiated at a very low dose and escalated gradually over 16 weeks to reach the maintenance dose. Each step lasts four weeks. The dose is injected subcutaneously once per week.

Step 1: 0.25 mg Weekly (Weeks 1-4)

The 0.25 mg starting dose is not a therapeutic dose for weight loss. Its sole purpose is to allow your gastrointestinal system to adapt to semaglutide. Most patients experience very few side effects at this dose. Do not be discouraged if you see little change in appetite or weight during this phase — that is expected. The goal here is simply tolerability.

Step 2: 0.5 mg Weekly (Weeks 5-8)

The first meaningful escalation. At 0.5 mg, many patients begin to notice appetite reduction and the early effects of GLP-1 receptor activation. Some patients experience nausea, particularly in the first week or two after the dose increase. This typically subsides as the body adjusts.

Step 3: 1.0 mg Weekly (Weeks 9-12)

The 1.0 mg dose produces more significant appetite suppression and often noticeable weight loss. This is also the dose at which GI side effects may be most pronounced during the transition period. Eating smaller meals, staying well hydrated, and avoiding high-fat foods during the escalation window can help manage discomfort.

Step 4: 1.7 mg Weekly (Weeks 13-16)

At 1.7 mg, patients are near the maximum therapeutic dose. This step is the penultimate stage before reaching the full maintenance dose. Weight loss typically accelerates at this level. Tolerability is usually better at this stage than earlier, because the body has had months to adapt to semaglutide.

Step 5: 2.4 mg Weekly (Week 17 Onward — Maintenance)

The 2.4 mg dose is the approved maintenance dose for Wegovy and the highest dose in the titration schedule. The landmark STEP 1 clinical trial demonstrated an average weight loss of approximately 14.9% of body weight over 68 weeks at this dose, with many participants losing significantly more. This dose is maintained indefinitely in eligible patients for chronic weight management.

Why Slow Escalation Matters

The 16-week titration schedule is not arbitrary — it is based on the pharmacology of semaglutide and clinical trial data. GLP-1 receptor agonists slow gastric emptying and alter gut hormone signaling, both of which can cause nausea, vomiting, and GI discomfort when the dose changes too quickly. Gradual escalation allows the GI tract to adapt progressively.

• Patients who skip dose levels or escalate faster experience significantly higher rates of severe nausea and vomiting.
• Rapid escalation is the most common cause of early medication discontinuation in clinical practice.
• Even if you feel excellent at a lower dose, follow the prescribed schedule — the next dose level can still produce unexpected side effects.
• The schedule is the same for all patients regardless of weight, age, or other factors — it is built into the product's FDA approval.

What to Do If You Cannot Tolerate a Dose Increase

Intolerance at a dose level is common, especially at the 0.5 mg, 1.0 mg, and 1.7 mg steps. You have options beyond simply pushing through or stopping the medication.

1. Extended stay at the current dose: Your prescriber can instruct you to remain at your current dose for an additional 4 weeks (or longer) before attempting the next escalation.
2. Step back down: If you escalated and are experiencing severe or persistent side effects, stepping back to the previous well-tolerated dose is appropriate and does not represent treatment failure.
3. Dose timing adjustment: Some patients find that changing when they inject (morning vs evening) or their relationship to meals around injection day helps with tolerability.
4. Anti-nausea support: Prescribers may recommend or prescribe short-term anti-nausea medication (e.g., ondansetron, promethazine) during particularly difficult escalation steps.
5. Contact your prescriber: Never adjust your dose schedule on your own — always communicate tolerance issues to your healthcare team.

What Determines Your Maintenance Dose

The prescribing information indicates that 2.4 mg is the target maintenance dose for all patients who can tolerate it. However, in practice, some patients remain at 1.7 mg if the 2.4 mg dose is not tolerated or if the patient is achieving adequate weight loss outcomes at the lower dose. The decision is made collaboratively between the patient and prescriber based on tolerability, efficacy, and clinical goals.

Wegovy vs Ozempic Dosing: Key Differences

Although both medications contain semaglutide, their dosing schedules and maximum doses are different, reflecting different FDA approval contexts.

• Wegovy maximum dose: 2.4 mg (for weight management)
• Ozempic maximum dose: 2.0 mg (for type 2 diabetes management)
• Wegovy titration: 5 steps over 16 weeks (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg)
• Ozempic titration: 4 steps (0.25 → 0.5 → 1.0 → 2.0 mg)
• Wegovy pens: Single-dose auto-injectors, one per week
• Ozempic pens: Multi-dose pens that last multiple weeks

Missed Dose Protocol for Wegovy

Wegovy follows the same missed dose rules as Ozempic. If a dose is missed, the action depends on how much time has passed since the missed injection.

• If fewer than 5 days have passed since the missed dose: Inject as soon as you remember, then resume your regular weekly schedule.
• If 5 or more days have passed: Skip the missed dose entirely. Do not double-dose. Take the next dose on your regularly scheduled day.
• Never take two doses in the same week to compensate for a missed dose.
• If you miss multiple consecutive doses, contact your prescriber — you may need to re-titrate at a lower dose to avoid a resurgence of side effects.

Wegovy's 16-week titration schedule is your roadmap to the full therapeutic dose. Respect it, communicate openly with your prescriber about any intolerance, and know that extending time at any step is a legitimate, well-supported clinical approach — not a setback.

Sources

• Wegovy (semaglutide) Prescribing Information. Novo Nordisk.
• Wilding et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM.